- Home
- CVAC vs XIFR Comparison
CVAC vs XIFR Comparison
Compare CVAC & XIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- XIFR
- Stock Information
- Founded
- CVAC 2000
- XIFR 2014
- Country
- CVAC Germany
- XIFR United States
- Employees
- CVAC N/A
- XIFR N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- XIFR
- Sector
- CVAC Health Care
- XIFR
- Exchange
- CVAC Nasdaq
- XIFR NYSE
- Market Cap
- CVAC 818.8M
- XIFR 874.5M
- IPO Year
- CVAC 2020
- XIFR N/A
- Fundamental
- Price
- CVAC $2.72
- XIFR $9.32
- Analyst Decision
- CVAC Hold
- XIFR
- Analyst Count
- CVAC 3
- XIFR 0
- Target Price
- CVAC $10.00
- XIFR N/A
- AVG Volume (30 Days)
- CVAC 634.5K
- XIFR 2.0M
- Earning Date
- CVAC 05-22-2025
- XIFR 04-22-2025
- Dividend Yield
- CVAC N/A
- XIFR 29.11%
- EPS Growth
- CVAC N/A
- XIFR N/A
- EPS
- CVAC N/A
- XIFR N/A
- Revenue
- CVAC $70,565,734.00
- XIFR $1,230,000,000.00
- Revenue This Year
- CVAC $742.57
- XIFR $13.82
- Revenue Next Year
- CVAC N/A
- XIFR $0.21
- P/E Ratio
- CVAC N/A
- XIFR N/A
- Revenue Growth
- CVAC 75.11
- XIFR 14.10
- 52 Week Low
- CVAC $2.22
- XIFR $7.97
- 52 Week High
- CVAC $5.28
- XIFR $35.15
- Technical
- Relative Strength Index (RSI)
- CVAC 36.80
- XIFR N/A
- Support Level
- CVAC $2.78
- XIFR N/A
- Resistance Level
- CVAC $3.33
- XIFR N/A
- Average True Range (ATR)
- CVAC 0.15
- XIFR 0.00
- MACD
- CVAC -0.01
- XIFR 0.00
- Stochastic Oscillator
- CVAC 1.61
- XIFR 0.00
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About XIFR XPLR INFRASTRUCTURE LP
NextEra Energy Partners LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.